CERS Q1 2020 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$335M

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$19M+6.3% YoY

Gross Profit

$10M55.3% margin

Operating Income

-$15M-82.8% margin

Net Income

-$16M-88.5% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

-11.0%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$215M

Total Liabilities

$103M

Stockholders' Equity

$112M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$18M	+6.3%
Gross Profit	$10M	$9M	+13.4%
Operating Income	-$15M	-$16M	+4.1%
Net Income	-$16M	-$19M	+12.4%

Revenue Segments

Product

$19M76%

Government Contract

$6M24%

Geographic Segments

Europe Middle East And Africa

$12M66%

North America

$6M33%

Other

$314,0002%